Central VA Bank

New Post Public Reply Private Reply Replies (0) Message Board
SaltyMutt
VectorVest Logo
Central VA Bank (CVBK)
$0.84
(0.00%)
Wednesday, February 13, 2013
CVBK is undervalued compared to its Price of $0.84 per share , has below average safety , and is currently rated a Hold.

Central VA Bank (CVBK)


Bank (Southeast)


Company Information

Business: Central Virginia Bankshares, Inc., incorporated on March 7, 1986, is the bank holding for Central Virginia Bank (the Bank). The principal business of the Bank is to attract deposits and to loan or invest those deposits.

Capital Appreciation

Value: Value is a measure of a stock 's current worth. CVBK has a current Value of $0.98 per share. Therefore, it is undervalued compared to its Price of $0.84 per share. Value is computed from forecasted earnings per share, forecasted earnings growth, profitability, interest, and inflation rates. Value increases when earnings, earnings growth rate and profitability increase, and when interest and inflation rates decrease. VectorVest advocates the purchase of undervalued stocks. At some point in time, a stock 's Price and Value always will converge.

RV (Relative Value): RV is an indicator of long-term price appreciation potential. CVBK has an RV of 1.05, which is fair on a scale of 0.00 to 2.00. This indicator is far superior to a simple comparison of Price and Value because it is computed from an analysis of projected price appreciation three years out, AAA Corporate Bond Rates, and risk. RV solves the riddle of whether it is preferable to buy High growth, High P/E stocks, or Low growth, Low P/E stocks. VectorVest favors the purchase of stocks with RV ratings above 1.00.



VectorVest Testimonials

RS (Relative Safety): RS is an indicator of risk. CVBK has an RS rating of 0.69, which is poor on a scale of 0.00 to 2.00. RS is computed from an analysis of the consistency and predictability of a company 's financial performance, debt to equity ratio, sales volume, business longevity, price volatility and other factors. A stock with an RS rating greater than 1.00 is safer and more predictable than the average stock in the VectorVest database. VectorVest favors the purchase of stocks of companies with consistent, predictable financial performance.

RT (Relative Timing): RT is a fast, smart, accurate indicator of a stock 's price trend. CVBK has a Relative Timing rating of 1.17, which is good on a scale of 0.00 to 2.00. RT is computed from an analysis of the direction, magnitude, and dynamics of a stock 's price movements over one day, one week, one quarter and one year time periods. Once a stock 's price has established a strong trend, it is expected to continue in that trend for the short-term. If a trend dissipates, RT will gravitate toward 1.00. RT will explode from bottoms, dive from tops, and reflect changes in price momentum. VectorVest favors the purchase of stocks with RT ratings above 1.00.

VST (VST-Vector): VST is the master indicator for ranking every stock in the VectorVest database. CVBK has a VST rating of 1.00, which is fair on a scale of 0.00 to 2.00. VST is computed from the square root of a weighted sum of the squares of RV, RS, and RT. Stocks with the highest VST ratings have the best combinations of Value, Safety and Timing. These are the stocks to own for above average, long-term capital appreciation. VectorVest advocates the purchase of safe, undervalued stocks rising in price.

Recommendation (REC): VectorVest gives a Buy, Sell, Hold recommendation on every stock, every day. CVBK has a Hold recommendation. REC reflects the cumulative effect of all the VectorVest parameters working together. These parameters are designed to help investors buy safe, undervalued stocks rising in price. They also help investors avoid or sell risky, overvalued stocks falling in price. VectorVest recommends that investors buy high VST-Vector, Buy-rated stocks in rising markets.

OR

Stop (Stop-Price): Stop is an indicator of when to sell a long position or cover a short position. CVBK has a Stop of $0.73 per share. This is $0.11 below below CVBK 's current closing Price. A stock 's Stop is computed from a 13 week moving average of its closing prices, and is fine-tuned according to the stock 's fundamentals. High RV, high RS stocks have lower Stops, and low RV, low RS stocks have higher Stops. In the VectorVest system, a stock gets a 'B ' or 'H ' recommendation if its Price is above its Stop and an 'S ' recommendation if its Price is below its Stop.

GRT (Earnings Growth Rate): GRT reflects a company 's one to three year forecasted earnings growth rate in percent per year. CVBK has a forecasted Earnings Growth Rate of 14.00%, which VectorVest considers to be good. GRT is computed from historical, current and forecasted earnings data. It is updated each week for every stock in the VectorVest database. GRT often foretells a stock 's future price trend. If a stock 's GRT trend is upward, the stock 's price will likely rise. If GRT is trending downward, the stock 's Price will probably fall. VectorVest favors the purchase of stocks whose GRT is rising and is greater than the sum of current inflation and interest rates, as shown weekly in our investment climate report.

EPS (Earnings per Share): EPS stands for leading 12 months Earnings Per Share. CVBK has a forecasted EPS of $0.07 per share. VectorVest determines this forecast from a combination of recent earnings performance and traditional fiscal and/or calendar year earnings forecasts.

P/E (Price to Earnings Ratio): P/E is a popular measure of stock valuation which shows the dollars required to buy one dollar of earnings. CVBK has a P/E of 12.00. This ratio may be deemed to be high or low depending upon your frame of reference. The average P/E of all the stocks in the VectorVest database is 38.97. P/E is computed daily using the formula: P/E = Price/EPS.

EY (Earnings Yield): EY reflects earnings per share as a percent of Price. EY is related to P/E via the formula, EY = 100 / (P/E), and may be used in place of P/E as a measure of valuation. EY has the advantages that it is always determinate and can reflect negative earnings. CVBK has an EY of 8.33 percent. This is above the current average of 2.55% for all the stocks in the VectorVest database. EY equals 100 x (EPS/Price).

GPE (Growth to P/E Ratio): GPE is another popular measure of stock valuation. It compares earnings growth rate to P/E ratio. CVBK has a GPE rating of 1.17. High growth stocks are believed to be able to justify high P/E ratios. A stock is commonly considered to be undervalued when GPE is greater than 1.00 and overvalued when GPE is below 1.00. Unfortunately, this rule of thumb does not take into account the effect of interest rates on P/E ratios. The operative GPE ratio of 1.00 is valid when and only when interest rates equal 10%. With long-term interest rates currently at 2.63%, the operative GPE ratio is 0.07. Therefore, CVBK may be considered to be undervalued.

Dividend Information

DIV (Dividend): VectorVest reports annual, regular, cash dividends as indicated by the most recent payments. Special distributions, one-time payments, stock dividends, etc., are not generally included in DIV. CVBK does not pay a dividend.

DY (Dividend Yield): DY reflects dividend per share as a percent of Price. CVBK does not pay a dividend, so it does not have a Dividend Yield rating . DY equals 100 x (DIV/Price). It is useful to compare DY with EY. If DY is not significantly lower than EY, the dividend payment may be in jeopardy.

DS (Dividend Safety): DS is an indicator of the assurance that regular cash dividends will be declared and paid at current or at higher rates for the foreseeable future. CVBK does not pay a dividend, so it does not have a Dividend Safety rating . Stocks with DS values above 75 typically have RS values well above 1.00 and EY levels that are much higher than DY.

DG (Dividend Growth Rate): Dividend Growth is a subtle yet important indicator of a company 's financial performance. It also provides some insight into the board 's outlook on the company 's ability to increase earnings. CVBK does not pay a dividend, so it does not have a Dividend Growth rating .

YSG (YSG-Vector): YSG is an indicator which combines DIV, DY and DG into a single value, and allows direct comparison of all dividend-paying stocks in the database. CVBK does not pay a dividend, so it does not have a YSG rating which is . Stocks with the highest YSG values have the best combinations of Dividend Yield, Safety and Growth. These are the stocks to buy for below current income and long-term growth.

Price-Volume Data

Price: CVBK closed on Wednesday, February 13, 2013 at $0.84 per share.

Open: CVBK opened trading at a price of $0.84 per share on Wednesday, February 13, 2013.

High: CVBK traded at a High price of $0.84 per share on Wednesday, February 13, 2013.

Low: CVBK traded at a Low price of $0.84 per share on Wednesday, February 13, 2013.

Close: CVBK closed on Wednesday, February 13, 2013 at $0.84 per share. (Close is also called Price in the VectorVest system)

Range: Range reflects the difference between the High and Low prices for the day. CVBK traded with a range of $0.00 per share on Wednesday, February 13, 2013.

$ Change: CVBK unchanged from the prior day 's closing Price.

%PRC: CVBK 's Price changed 0.00% from the prior day 's closing price.

Volume: CVBK traded 200 shares on Wednesday, February 13, 2013.

AvgVol: AvgVol is the 50 day moving average of daily volume as computed by VectorVest. CVBK has an AvgVol of 2,680 shares traded per day.

%Vol: %Vol reflects the percent change in today 's trading volume as compared to the AvgVol. %Vol equals ((Volume - AvgVol) / AvgVol ) * 100. CVBK had a %Vol of -92.54% on Wednesday, February 13, 2013

CI (Comfort Index): CI is an indicator which reflects a stock 's ability to resist severe and/or lengthy price declines. CVBK has a CI rating of 0.53, which is poor on a scale of 0.00 to 2.00. CI is quite different from RS in that it is based solely upon a stock 's long-term price history. VectorVest advocates the purchase of high CI stocks.

Sales / Market Capitalization Information

Sales: CVBK has annual sales of 15,000,000

Sales Growth: Sales Growth is the Sales Growth Rate in percent over the last 12 months. CVBK has a Sales Growth of -19.00% per year. This is very poor. Sales Growth is updated each week for every stock. It is often useful to compare Sales Growth to Earnings Growth to gain an insight into a company 's operations.

Sales Per Share (SPS): CVBK has annual sales of $5.63 per share. SPS can be used as a measure of valuation when comparing stocks within an Industry Group.

Price to Sales Ratio (P/S): CVBK has a P/S of 0.15. This ratio is also used as a measure of valuation. Here, too, it is useful when comparing stocks within an Industry Group.

Shares: CVBK has 2,000,000 shares of stock outstanding.

Market Capitalization: CVBK has a Market Capitalization of 2,000,000. Market Capitalization is calculated by multiplying price times shares outstanding.

Business Sector: CVBK has been assigned to the Bank Business Sector. VectorVest classifies stocks into over 200 Industry Groups and 40 Business Sectors.

Industry Group: CVBK has been assigned to the Bank (Southeast) Industry Group. VectorVest classifies stocks into over 200 Industry Groups and 40 Business Sectors.

For another stock analysis, please click here.

Please do not reply to this email. For answers to your questions, please call 1-888-658-7638, or email us at support@vectorvest.com .

Copyright 2010 by VectorVest, Inc. All Rights Reserved.
20472 Chartwell Center Drive, Cornelius NC 28031
For additional information, call 1-888-658-7638, e-mail to support@vectorvest.com ,
or visit our internet site at http://www.vectorvest.com

For international phone numbers please click here.

DISCLAIMER: VectorVest is licensed by VectorVest, Inc., and is protected by United States copyright laws and international treaty provisions. The information contained herein is for your exclusive, personal use only. You may print a single copy of any stock analysis for your exclusive use, but it is not to be reproduced for distribution without the expressed written consent of VectorVest, Inc. You should be aware of the risks involved in stock investing, and you use the material contained herein at your own risk. This material is believed to be reliable, but neither VectorVest, Inc., nor any of its suppliers guarantee its accuracy or validity, nor are they responsible for any errors or omissions which may have occurred. The analysis, ratings, and/or recommendations made by VectorVest, and/or any of its suppliers do not provide, imply, or otherwise constitute a guarantee of performance.

VectorVest is comprised of reports embodying a unique system of stock analysis. All contents and recommendations are based on data and sources believed to be reliable, but accuracy and completeness cannot be guaranteed. Users should be aware of the risks involved in stock investments. It should not be assumed that future results will be profitable or will equal past performance, real, indicated or implied. VectorVest and/or its principals may purchase or sell any of the securities cited herein. VectorVest and the logostyle, geometric design are, individually and collectively, service marks owned by VectorVest, Inc. VectorVest is published daily by VectorVest, Inc. 20472 Chartwell Center Drive Cornelius, NC 28031 704-895-4095

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Interventional Ophthalmology: Early Eye Care Strategies Evolve

Updated Category News Views 0

Proactive Eye Care: The New Frontier Today's eye care landscape is all about catching things early, folks. Long gone are the days of waiting for eyesight to deteriorate before rushing to the nearest eye doc. In Racine, interventional ophthalmology is shifting gears towards preventive care—looking ahead to stop eye diseases in their tracks before they muck up a person's...

Continue Reading
Park Systems Expands in the Pacific Northwest

Updated Category News Views 6

Strategic Move into Hillsboro Sparks Industry Buzz Park Systems, already a heavyweight in the nanometrology arena, just made a bold play with the opening of its latest regional office. Nestled in the tech-centric town of Hillsboro, Oregon, this hub is set to redefine how they handle technical support and customer management across the Pacific Northwest. It's like they're...

Continue Reading
Supernova SPAC Lawsuit: Settlement Proposed, $3M on Table

Updated Category News Views 2

Legal Clouds Over Supernova's SPAC Adventure Alright, folks, buckle up, because whenever you mix SPACs and lawsuits, you're in for a roller coaster. Supernova Partners Acquisition Company, Inc. stands right at the heart of a class action lawsuit, and it's been cooking ever since the court in Delaware gave it a nudge forward. Settlement Talk: What's on the Table? So here's...

Continue Reading
Summit Tackles BRI Infrastructure's Role in Global SDGs

Updated Category News Views 3

A Bold Gathering with Lofty Goals Ever watch a room of world leaders debate the finer nuances of sustainable infrastructure? That's something Singapore pulled off on September 6, 2026, with the Second Global Business Summit on Belt and Road Infrastructure Investment. These aren't just any ordinary suits sitting around in a conference room. We're talking about a dynamic...

Continue Reading
Thermoplastic Polyimide: A $0.86 Billion Market by 2032

Updated Category News Views 0

It's not often you get hyped about a compound with a name like 'thermoplastic polyimide,' but hold your horses—this isn't just any chemical. If you're watching markets with a sharp eye, you’ll see this thing estimated at $0.56 billion in 2026, gunning for a hefty $0.86 billion by 2032. We're talking about a solid 7.4% CAGR ride here folks, according to new data from...

Continue Reading
TECNO CAMON Slim 5G: Where Art Meets Tech

Updated Category News Views 1

Unveiling the TECNO CAMON Slim 5G Okay, so imagine a tech brand saying, 'Why not make a phone that’s as much an art piece as it is a gadget?' TECNO just pulled this off with their latest CAMON Slim 5G. The thing's a sleek marvel measuring in at just 6.39mm. Seems like they took a fat-free diet approach to phone design, and not on the digital calories either. A Slim Body...

Continue Reading
Smart City Expo 2026: Innovations in Urban Living

Updated Category News Views 2

Peeling Back the Layers at Smart City Expo 2026 If you can't feel the pulse of change in urban landscapes, you're about to miss the bus. November's Smart City Expo World Congress (SCEWC) is the stage where cities showcase their flashy new upgrades—not just to look sleek but to make tangible, far-reaching impacts. From November 3 to 5, the city's Gran Via venue will host...

Continue Reading
Regeneron Faces Class Action Over Tumultuous Trial Results

Updated Category News Views 0

Regeneron's Meltdown: A Bitter Pill for Investors Let’s dive headlong into the mess Regeneron Pharmaceuticals (NASDAQ:REGN) finds itself in—a classic nightmare scenario for investors. News broke like an old valve bursting, and suddenly, the market's love for Regeneron ran ice-cold. Who's to blame this time? Well, you might want to point a finger at the failed Phase 3...

Continue Reading
Ping An Climbs Sustainability Ladder, Scores A+ Rating

Updated Category News Views 4

Sustainability Triumph for Ping An: A+ Upgrade Ping An Insurance (Group) Company of China, Ltd. is having quite the moment, snagging an A+ in the latest 2026 Sustainability Rating from Hang Seng Indexes Company. This ain't just a one-time pat on the back—it's the third year of consecutive improvement. Looks like Ping An's focus on ESG efforts is finally getting the...

Continue Reading
Nuix Leverages AI for Transformative Legal Review

Updated Category News Views 1

Nuix Unveils AI Innovations in Legal Review Diving headfirst into the evolving world of legal technology, Nuix has just rolled out some serious upgrades to its eDiscovery toolkit. By plucking AI right out of the data science ethers, they're not just dabbling in futuristic tech—they're planting generative AI at the heart of legal review on their SaaS platform, Nuix...

Continue Reading

Top 5 Most Recently Viewed Articles

AlphaSense Drives Healthcare Innovation with AI Insights

Updated Category News Views 694

AlphaSense Enhances Healthcare Industry Insights The company strengthens its dominance in the industry as the focus shifts to innovation and market trends. As healthcare reaches a pivotal point of transformation, AlphaSense is leading the way with unmatched AI-driven market intelligence. With its advanced search capabilities over a vast trove of high-quality business...

Continue Reading
Intchains Group Limited's ETH Strategy and Financial Update

Updated Category News Views 130

Intchains Group Limited: A Look Into Their Latest Financial Results As a noteworthy player in the cryptocurrency landscape, Intchains Group Limited (NASDAQ: ICG) recently shared intriguing insights on its financial performance and operational strategies focused on Ethereum (ETH) as of June 30, 2025. This update serves to highlight their advancements in ETH holdings and...

Continue Reading
Krystal Biotech Sets Stage for Stifel 2024 Conference Insights

Updated Category News Views 181

Krystal Biotech to Attend Stifel 2024 Healthcare Conference Krystal Biotech, Inc. (NASDAQ: KRYS), a notable player in the biotechnology sector, is gearing up to be a part of the Stifel 2024 Healthcare Conference set to take place shortly. The event is highlighted by prominent presentations, including one from Krish S. Krishnan, the Company’s Chairman and Chief Executive...

Continue Reading
The Growth Journey of Cognex: A 15-Year Investment Insight

Updated Category News Views 151

Understanding the Long-Term Value of Cognex Investments Cognex (NASDAQ: CGNX) has demonstrated remarkable market performance, surpassing the overall market by an impressive 3.2% annually over the past decade and a half. This stellar performance translates to an average annual return of approximately 14.78%. As of now, Cognex holds a market capitalization valued at $9.55...

Continue Reading
Autodesk Inc Reaches New Heights with Stock Performance Surge

Updated Category News Views 63

Autodesk Inc Achieves Milestone Stock Performance Autodesk Inc. (NASDAQ: ADSK) has marked a significant milestone by reaching a 52-week high at $279.64, reflecting an upward trajectory in its stock performance. Known for its innovative solutions in the fields of architecture, engineering, and construction, Autodesk has become a key player in the software industry. Over...

Continue Reading